# DragonFly M2 Pivotal Study

> **NCT07243197** · NA · NOT_YET_RECRUITING · sponsor: **Hangzhou Valgen Medtech Co., Ltd** · enrollment: 53 (estimated)

## Conditions studied

- Mitral Valve (MV) Regurgitation

## Interventions

- **DEVICE:** DragonFly M2 Transcatheter Mitral Valve Repair System

## Key facts

- **NCT ID:** NCT07243197
- **Lead sponsor:** Hangzhou Valgen Medtech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2026-07-31
- **Final completion:** 2031-06-30
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07243197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07243197, "DragonFly M2 Pivotal Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07243197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
